Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. | Apnimed’s star sleep apnea ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

A sleep apnea drug is already available in the U.S. Late ... bind to two gut receptors to spark metabolic effects, such as weight loss. The way Zepbound works to treat OSA is unknown, but obesity ...

May 8 (UPI) --Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says. The drop in blood oxygen levels that occurs during a ...